Archive: Jul 2022

  1. Tirzepatide Could Offer ‘Hope on the Horizon’ for Obese Patients

    Last month, the New England Journal of Medicine published an article on the clinical trial of Tirzepatide – a medication used to treat Type 2 diabetes – as a possible medication to treat obesity. More than 2,500 adults with a body-mass index of 30 or more, or 27 or more with at least one weight-related Read More